Chinese Journal of Pharmacovigilance ›› 2025, Vol. 22 ›› Issue (8): 956-960.
DOI: 10.19803/j.1672-8629.20240725
WANG Yinghe, LI Mingqi, ZHAO Xiaolu, MA Yuehong*
Received:
2024-09-13
Online:
2025-08-15
Published:
2025-08-13
CLC Number:
WANG Yinghe, LI Mingqi, ZHAO Xiaolu, MA Yuehong. Different Functions of Autophagy in Diseased Livers[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 956-960.
[1] HARNETT MM, PINEDA MA, LATR DE LAT P, et al. From Christian de Duve to Yoshinori Ohsumi: More to Autophagy than Just Dining at Home[J]. Biomedical Journal, 2017, 40(1): 9-22. [2] MIZUSHIMA N, LEVINE B.Autophagy in Human Diseases[J]. The New England Journal of Medicine, 2020, 383(16): 1564-1576. [3] HUANG J, JIANG JJ, SHAO HJ, et al.Disease Burden Analysis of Alcoholic Liver Disease in China, 1990-2019[J]. Modern Preventive Medicine(现代预防医学), 2023, 50(20): 3800-3805, 3811. [4] ZHANG ML.Rao Hui-Ying: Current Status of Prevention and Treatment of Non-Alcoholic Fatty Liver Disease[J]. Dr Liver(肝博士), 2023(6): 11-12. [5] LI SH, ZHANG LI, ZHANG RX.Assessment of the Disease Burden of Viral Hepatitis C in China, 1990-2019[J]. Chinese Journal of Infection Control(中国感染控制杂志), 2022, 21(10): 971-976. [6] LIU LL, NIU JQ, CE. Modelling to Assess the Burden of Disease of Non-Alcoholic Fatty Liver Disease in Multiple Countries from 2016-2030[J]. Journal of Clinical Hepatobiliary Diseases(临床肝胆病杂志), 2018, 34(8): 1598. [7] NIU L, THIELE M, GEYER PE, et al.Noninvasive Proteomic Biomarkers for Alcohol-Related Liver Disease[J]. Nature Medicine, 2022, 28(6): 1277-1287. [8] TANG L, YANG F, FANG Z, et al.Resveratrol Ameliorates Alcoholic Fatty Liver by Inducing Autophagy[J]. The American Journal of Chinese Medicine, 2016, 44(6): 1207-1220. [9] YUAN C, LIAN QH, NI BB, et al.Screening and Bioinformatics Analysis of Key Autophagy Genes in Alcoholic Hepatitis[J]. Organ Transplantation(器官移植), 2024, 15(1): 90-101. [10] LIU L, XIE P, LI W, et al.Augmenter of Liver Regeneration Protects against Ethanol-Induced Acute Liver Injury by Promoting Autophagy[J]. The American Journal of Pathology, 2019, 189(3): 552-567. [11] LIU R, YI X, WU XL, et al.Effects of Pueraria Mirifica Deconstructing and Lipolysis Soup on Energy Metabolism in Liver Tissues of Mice with Alcoholic Liver Disease[J]. Journal of Beijing University of Traditional Chinese Medicine(北京中医药大学学报), 2024, 47(5):1-18. [12] ZHAO S, GUO Y, YIN X. Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease[J]. Frontiers in Bioscience-Landmark, 2024, 29(1): 30. [13] MENG ZQ.Study on the Mechanism of Action of Apigenin in Activating Autophagy to Alleviate High-Fat Diet-Induced Liver Injury[D]. Jilin: Jilin University, 2023. [14] LI Y L, LI XQ, WANG YD, et al.Metformin Alleviates Inflammatory Response in Non-Alcoholic Steatohepatitis by Restraining Signal Transducer and Activator of Transcription 3-Mediated Autophagy Inhibition in vitro and in vivo[J]. Biochemical and Biophysical Research Communications, 2019, 513(1): 64-72. [15] YAN LS, ZHANG SF, LUO G, et al.Schisandrin B Mitigates Hepatic Steatosis and Promotes Fatty Acid Oxidation by Inducing Autophagy through AMPK/mTOR Signaling Pathway[J]. Metabolism: Clinical and Experimental, 2022, 131: 155200. [16] MA S, CHEN X, TAN Q, et al.An Engineered Novel Lentivector Specifically Transducing Dendritic Cells and Eliciting Robust HBV-SPecific CTL Response by Upregulating Autophagy in T Cells[J]. Cell Cycle, 2018, 17(10): 1220-1234. [17] ZHANG Y, HUA L, LIN C, et al.Pien-Tze-Huang Alleviates CCl(4)-Induced Liver Fibrosis through the Inhibition of HSC Autophagy and the TGF-β1/Smad2 Pathway[J]. Frontiers in Pharmacology, 2022, 13: 937484. [18] CAO Y, MAI W, LI R, et al.Macrophages Evoke Autophagy of Hepatic Stellate Cells to Promote Liver Fibrosis in NAFLD Mice Via the PGE2/EP4 Pathway[J]. Cellular and Molecular Life Sciences: CMLS, 2022, 79(6): 303. [19] XIU AY, DING Q, LI Z, et al.Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway[J]. Drug Design, Development and Therapy, 2021, 15: 3643-3659. [20] LI MQ, ZHAO XL, GAO XY, et al.Progress in the Study of the Link between Epithelial Mesenchymal Transition and Liver Fibrosis[J]. China Pharmacovigilance(中国药物警戒), 2024, 21(4): 464-468, 472. [21] KALLURI R, WEINBERG RA.The Basics of Epithelial-Mesenchymal Transition[J]. The Journal of Clinical Investigation, 2009, 119(6): 1420-1428. [22] WANG YJ, XIE XL, JIANG HQ.Regulation of Epithelial-Mesenchymal Transition in Liver Fibrosis and Progress of Targeted Therapy[J]. Journal of Clinical Hepatobiliary Diseases(临床肝胆病杂志), 2021, 37(1): 165-168. [23] CHOWDHURY O, GHOSH S, DAS A, et al.Sustained Systemic Inflammation Increases Autophagy and Induces EMT/Fibrotic Changes in Mouse Liver Cells: Protection by Melatonin[J]. Cellular Signalling, 2023, 101: 110521. [24] VERMA S, ISHTEYAQUE S, WASHIMKAR KR, et al.Mitochondrial-Mediated Nuclear Remodeling and Macrophage Polarizations: a Key Switch from Liver Fibrosis to HCC Progression[J]. Experimental Cell Research, 2024, 434(1): 113878. [25] GAO J, WEI B, DE-ASSUNCAO TM, et al.Hepatic Stellate Cell Autophagy Inhibits Extracellular Vesicle Release to Attenuate Liver Fibrosis[J]. Journal of Hepatology, 2020, 73(5): 1144-1154. [26] YU Q, CHENG P, WU J, et al.PPARγ/NF-κB and TGF-β1/Smad Pathway are Involved in the Anti-Fibrotic Effects of Levo-Tetrahydropalma-tine on Liver Fibrosis[J]. Journal of Cellular and Molecular Medicine, 2021, 25(3): 1645-1660. [27] LI L, CHENG ZM, HE HZ, et al.Pirfenidone Promotes Apoptosis by Inhibiting Hepatic Stellate Cell Autophagy in the Treatment of Liver Fibrosis[J]. Journal of Interventional Radiology(介入放射学杂志), 2023, 32(7): 651-659. [28] ZHENG Y, ZHAO T, WANG J, et al.Curcumol Alleviates Liver Fibrosis through Inducing Autophagy and Ferroptosis in Hepatic Stellate Cells[J]. FASEB Journal, 2022, 36(12): e22665. [29] KONG Z, LIU R, CHENG Y.Artesunate Alleviates Liver Fibrosis by Regulating Ferroptosis Signaling Pathway[J]. Biomedicine & Pharmacotherapy, 2019, 109: 2043-2053. [30] MENG D, LI Z, WANG G, et al.Carvedilol Attenuates Liver Fibrosis by Suppressing Autophagy and Promoting Apoptosis in Hepatic Stellate Cells[J]. Biomedicine & Pharmacotherapy, 2018, 108: 1617-1627. [31] ZHANG XW, ZHOU JC, PENG D, et al.Disrupting the TRIB3-SQSTM1 Interaction Reduces Liver Fibrosis by Restoring Autophagy and Suppressing Exosome-Mediated HSC Activation[J]. Autophagy, 2020, 16(5): 782-796. [32] LYU C, MAO DWE, SHI QL, et al.Progress on the Mechanism of Anti-Hepatic Fibrosis of Traditional Chinese Medicine and Its Combination[J]. Chinese Journal of Experimental Formulas(中国实验方剂学杂志), 2020, 26(4): 242-250. [33] ZHANG WF, WU SS, DAI M, et al.Mechanism of Mitochondrial Autophagy Inhibition of Hepatic Stellate Cell Activation by Soft Liver Fibre Particles Based on miR-135a/FOXO1/PINK1 Pathway[J]. Chinese Journal of Traditional Chinese Medicine(中华中医药学刊), 2024, 42(4): 1-14. [34] ZHOU L, LIANG Q, LI Y, et al.Collagenase-I Decorated Co-Delivery Micelles Potentiate Extracellular Matrix Degradation and Hepatic Stellate Cell Targeting for Liver Fibrosis Therapy[J]. Acta Biomaterialia, 2022, 152: 235-254. [35] CHEN W, ZHANG Z, YAO Z, et al.Activation of Autophagy is Required for Oroxylin A to Alleviate Carbon Tetrachloride-Induced Liver Fibrosis and Hepatic Stellate Cell Activation[J]. International Immunopharmacology, 2018, 56: 148-155. [36] HAMMOUTENE A, BIQUARD L, LASSELIN J, et al.A Defect in Endothelial Autophagy Occurs in Patients with Non-Alcoholic Steatohepatitis and Promotes Inflammation and Fibrosis[J]. Journal of Hepatology, 2020, 72(3): 528-538. [37] KONG D, ZHANG Z, CHEN L, et al.Curcumin Blunts Epithelial-Mesenchymal Transition of Hepatocytes to Alleviate Hepatic Fibrosis through Regulating Oxidative Stress and Autophagy[J]. Redox Biology, 2020, 36: 101600. [38] HAO Y, FENG D, YE H, et al.Nobiletin Alleviated Epithelial-Mesenchymal Transition of Hepatocytes in Liver Fibrosis Based on Autophagy-Hippo/YAP Pathway[J]. Molecular Nutrition & food Research, 2023: e2300529. [39] CHAO X, QIAN H, WANG S, et al.Autophagy and Liver Cancer[J]. Clinical and Molecular Hepatology, 2020, 26(4): 606-617. |
[1] | BU Zixuan, XUE Mengwei, TIAN Jiawei, KE Kaile, WANG Ziying, LI Xiao, LU Tiangong. Interventions of Guizhi Fuling Pills in Properties of Ovarian Cancer Stem Cells [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 263-270. |
[2] | SHEN Xue, JIANG Haiyan, FAN Xiaoyu, LI Wanfang, BAO Jie, HE Bosai, JIN Hongtao. Developments in research on combination drugs for hepatic fibrosis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 985-990. |
[3] | YUAN Zhexin, WANG Wenqing, HUANG Yifan, ZHANG Rongzhen, TANG Yucheng, ZHANG Linghan, ZHANG Haiying, LIU Yan. MCOLN1 ameliorates atherosclerosis by regulating lysosomal autophagy [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 781-786. |
[4] | YAO Weijie, YAN Shiqi, YUAN Sisi, GONG Leilei, FENG Xin. Roles of Yangxue Antai prescription in improving endometrial epithelial-mesenchymal transformation and decidualization in recurrent spontaneous abortion mice by regulating autophagy [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 547-552. |
[5] | YAO Weijie, YAN Shiqi, YUAN Sisi, GONG Leilei, FENG Xin. Effect of Yangxue Antai prescription on the regulation of placental angiogenesis and autophagy in recurrent spontaneous abortion mice [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 371-377. |
[6] | YAO Weijie, YAN Shiqi, YUAN Sisi, GONG Leilei, FENG Xin. Study on the mechanism of Yangxue Antai prescription regulating autophagy in the treatment of recurrent spontaneous abortion mice [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 378-385. |
[7] | LI Mingqi, ZHAO Xiaolu, GAO Xiaoyang, MA Yuehong. Research progress in correlations between epithelial-mesenchymal transition and hepatic fibrosis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 464-468. |
[8] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[9] | ZHENG Enqi, BAI Xue. Analysis and Research on the Mechanism of Cerebral Ischemia in China [J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1398-1404. |
[10] | LIU Ying, SONG Xuyu, SUN Rong. Research Progress in Mechanisms of Rhubarb Anthraquinone Based on Hepatic Lipid Regulation and Hepatotoxicity [J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1432-1440. |
[11] | YANG Zhenzhen, CHANG Cheng, GAO Na, ZHANG Xiaolin, SONG Yinsen, LIU Ying, FAN Tianli. Molecular mechanism of luteolin for inhibiting esophageal squamous cell carcinoma based on network pharmacology and in vitro studies [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 992-1001. |
[12] | LI Yamei, SHUI Rong. Research progress in tofacitinib for juvenile idiopathic arthritis [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 956-960. |
[13] | WAN Wei, CHANG Jun, ZHU Du, CHEN Wen. Research progress on hesperetin and its derivatives against fibrosis [J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 579-584. |
[14] | PENG Lili, LIU Wei, TANG Ren, LI Lan, FAN Yan. Literature Analysis of Adverse Drug Reactions/Events Induced by Thiamazole [J]. Chinese Journal of Pharmacovigilance, 2018, 15(7): 404-410. |
[15] | LI Lan, XIA Dongsheng, TIAN Chunhua, PENG Lili, GAO Yunjuan. Analysis and Consideration on Safety Risk of Thiamazole Tablets [J]. Chinese Journal of Pharmacovigilance, 2018, 15(7): 393-397. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||